Smith & Nephew SNATS - 21 Year Stock Price History | SNN

Historical daily share price chart and data for Smith & Nephew SNATS since 1999 adjusted for splits. The latest closing stock price for Smith & Nephew SNATS as of January 28, 2020 is 49.53.
  • The all-time high Smith & Nephew SNATS stock closing price was 50.57 on January 24, 2020.
  • The Smith & Nephew SNATS 52-week high stock price is 50.69, which is 2.3% above the current share price.
  • The Smith & Nephew SNATS 52-week low stock price is 37.67, which is 23.9% below the current share price.
  • The average Smith & Nephew SNATS stock price for the last 52 weeks is 43.66.
Smith & Nephew SNATS Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 48.9200 48.2700 50.5700 47.8500 49.5300 3.04%
2019 42.7863 36.4000 48.5900 35.5100 48.0700 28.60%
2018 36.3446 34.9000 39.4400 32.4000 37.3800 6.77%
2017 34.1090 29.9900 38.5000 29.9000 35.0100 16.39%
2016 32.3880 34.8000 35.0600 27.1100 30.0800 -15.51%
2015 35.0108 35.9500 37.7800 32.4800 35.6000 -3.10%
2014 32.9098 28.3360 38.9080 28.3360 36.7400 28.03%
2013 24.0164 22.2920 28.7400 21.1600 28.6960 29.49%
2012 20.3023 19.5560 22.4640 18.0520 22.1600 15.06%
2011 20.5597 21.0400 24.0760 16.8680 19.2600 -8.37%
2010 19.1278 20.6520 21.5760 16.5160 21.0200 2.54%
2009 15.8762 13.0400 20.5520 12.2280 20.5000 58.67%
2008 21.6752 23.0520 27.4280 12.1560 12.9200 -43.75%
2007 24.1161 20.9480 27.1080 20.8280 22.9680 9.73%
2006 17.8203 18.9440 21.0600 14.7800 20.9320 12.90%
2005 19.1965 20.3320 21.1320 16.1040 18.5400 -10.45%
2004 19.6518 16.7360 23.2000 16.3200 20.7040 23.47%
2003 13.2164 12.3720 16.9200 10.7200 16.7680 36.55%
2002 11.5938 12.0600 12.7820 9.6800 12.2800 0.99%
2001 9.9700 9.2000 12.1800 8.3700 12.1600 31.83%
2000 7.9306 8.2180 9.2240 6.1403 9.2240 12.01%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $22.117B $4.904B
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $159.868B 27.90
Medtronic (MDT) Ireland $159.853B 22.08
Stryker (SYK) United States $80.144B 26.95
Boston Scientific (BSX) United States $60.227B 28.43
Baxter (BAX) United States $46.348B 28.10
EssilorLuxottica Societe Anonyme (ESLOY) France $32.970B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.400B 19.07
Lonza Group Ag (LZAGY) Switzerland $30.070B 0.00
Coloplast (CLPBY) Denmark $27.194B 41.97
Terumo (TRUMY) Japan $27.183B 0.00
ResMed (RMD) United States $23.349B 43.07
Sunny Optical Technology (SNPTF) China $19.732B 0.00
Insulet (PODD) United States $11.904B 566.35
Bio-Rad Laboratories (BIO) United States $11.075B 53.16
Perrigo (PRGO) Ireland $7.998B 14.91
Canopy Growth (CGC) Canada $7.913B 0.00
William Demant Holdings (WILYY) Denmark $7.896B 0.00
DiaSorin S.p.A (DSRLF) Italy $7.357B 0.00
Hill-Rom Holdings (HRC) United States $7.341B 21.13
GN STORE NORD (GNNDY) Denmark $6.158B 0.00
Haemonetics (HAE) United States $5.446B 36.80
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
NuVasive (NUVA) United States $4.013B 31.60
ICU Medical (ICUI) United States $3.880B 25.30
Neogen (NEOG) United States $3.553B 59.13
GW Pharmaceuticals (GWPH) United Kingdom $3.537B 0.00
Quidel (QDEL) United States $3.250B 30.84
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.132B 0.00
Agios Pharmaceuticals (AGIO) United States $3.123B 0.00
National Vision Holdings (EYE) United States $2.908B 65.64
Aurora Cannabis (ACB) Canada $2.168B 0.00
Cardiovascular Systems (CSII) United States $1.807B 0.00
InMode (INMD) Israel $1.563B 0.00
AtriCure (ATRC) United States $1.486B 0.00
TG Therapeutics (TGTX) United States $1.344B 0.00
Aphria (APHA) $1.331B 0.00
VAREX IMAGING (VREX) United States $1.175B 23.49
Phibro Animal Health (PAHC) United States $1.024B 19.17
NanoString Technologies (NSTG) United States $1.005B 0.00
PetIQ (PETQ) United States $0.873B 21.30
Eagle Pharmaceuticals (EGRX) United States $0.778B 29.81
Quanterix (QTRX) United States $0.752B 0.00
LeMaitre Vascular (LMAT) United States $0.729B 40.99
Lantheus Holdings (LNTH) United States $0.708B 17.68
Omeros (OMER) United States $0.674B 0.00
Cerus (CERS) United States $0.641B 0.00
Surmodics (SRDX) United States $0.548B 56.80
MacroGenics (MGNX) United States $0.529B 0.00
OraSure Technologies (OSUR) United States $0.490B 29.41
Organigram Holdings (OGI) Canada $0.451B 0.00
Meridian Bioscience (VIVO) United States $0.408B 14.02
HEXO (HEXO) $0.401B 0.00
Owens & Minor (OMI) United States $0.394B 14.58
Utah Medical Products (UTMD) United States $0.385B 27.90
Zynex (ZYXI) United States $0.331B 37.48
BioLife Solutions (BLFS) United States $0.310B 126.17
Bovie Medical (APYX) United States $0.274B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.256B 0.00
Female Health (VERU) United States $0.243B 0.00
Vapotherm (VAPO) United States $0.241B 0.00
Repro-Med Systems (KRMD) United States $0.233B 0.00
United Health Products (UEEC) United States $0.224B 0.00
Viemed Healthcare (VMD) United States $0.209B 22.00
Liberty Health Sciences (LHSIF) Canada $0.178B 0.00
InfuSystems Holdings (INFU) United States $0.171B 861.00
Rockwell Medical (RMTI) United States $0.164B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.164B 0.00
Cytosorbents (CTSO) United States $0.149B 0.00
Fonar (FONR) United States $0.132B 9.32
Chimerix (CMRX) United States $0.117B 0.00
MTech Acquisition (KERN) United States $0.096B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.090B 0.00
Surface Oncology (SURF) United States $0.086B 0.00
United-Guardian (UG) United States $0.083B 20.95
MRI Interventions (MRIC) United States $0.078B 0.00
Nephros (NEPH) United States $0.077B 0.00
Chembio Diagnostics (CEMI) United States $0.074B 0.00
FSD PHARMA INC (HUGE) $0.049B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Trinity Biotech (TRIB) Ireland $0.030B 0.00
GUARDION HEALTH (GHSI) United States $0.024B 0.00
NF Energy Saving (BIMI) China $0.023B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.014B 0.00
Senestech (SNES) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.008B 0.00
Myomo (MYO) United States $0.006B 0.00
Valeritas Holdings (VLRX) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00